Hepatitis C virus reinfection-more to come?

Affiliations

¹ Center for Infectiology, Berlin, 10439, Germany. Electronic address: Ingiliz@zibp.de.
² Department of Medicine I, University of Bonn, Bonn, Germany.

Comment

Patrick Ingiliz et al. Lancet Gastroenterol Hepatol. 2017 Mar.

. 2017 Mar;2(3):150-151.

doi: 10.1016/S2468-1253(16)30223-0. Epub 2016 Dec 23.

¹ Center for Infectiology, Berlin, 10439, Germany. Electronic address: Ingiliz@zibp.de.
² Department of Medicine I, University of Bonn, Bonn, Germany.

No abstract available

Comment on

Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
Islam N, Krajden M, Shoveller J, Gustafson P, Gilbert M, Buxton JA, Wong J, Tyndall MW, Janjua NZ; British Columbia Hepatitis Testers Cohort (BC-HTC) team. Islam N, et al. Lancet Gastroenterol Hepatol. 2017 Mar;2(3):200-210. doi: 10.1016/S2468-1253(16)30182-0. Epub 2016 Dec 23. Lancet Gastroenterol Hepatol. 2017. PMID: 28404135

Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs.
Yeung A, Palmateer NE, Dillon JF, McDonald SA, Smith S, Barclay S, Hayes PC, Gunson RN, Templeton K, Goldberg DJ, Hickman M, Hutchinson SJ. Yeung A, et al. J Hepatol. 2022 Mar;76(3):549-557. doi: 10.1016/j.jhep.2021.09.038. Epub 2021 Oct 9. J Hepatol. 2022. PMID: 34634387 Free PMC article.
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy.
Huang CF, Yu ML. Huang CF, et al. Clin Mol Hepatol. 2020 Jul;26(3):251-260. doi: 10.3350/cmh.2020.0018. Epub 2020 Mar 19. Clin Mol Hepatol. 2020. PMID: 32188235 Free PMC article. Review.